Published mark
Moderna
Moderna, Inc.
NASDAQ: MRNA. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:3ff53494-3800-4bc5-a2c8-0e3e54897d6c
- SEC CIK
- 0001682852
- Website
- www.modernatx.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Sep 30, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Not published
- Chair
- Not published
- Independent
- 7 / 88 directors published
- Published claims
- 335 distinct sources
- Evidence records
- 60 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Juan Andres executive of Moderna, effective 2026-10-05.
EffectiveEffective Oct 5, 2026E4
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Operating Officer | Juan Andres | Oct 2026 | current | Source reportedE4 |
Board of directors
Evidence8 directors published. 7 of 8 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Abbas Hussain | Independent | 2024 | AuditAudit; Product and TechnologyProduct and Technology | Source reportedE3 |
| David Rubenstein | Independent | 2024 | Nominating and Corporate Governance | Source reportedE3 |
| Elizabeth Nabel | Independent | 2015 | Compensation and TalentCompensation and Talent; Product and TechnologyProduct and Technology | Source reportedE3 |
| Elizabeth Tallett | Independent | 2020 | Audit, chairAudit · Chair; Compensation and TalentCompensation and Talent | Source reportedE3 |
| François Nader, M.D. | Independent | 2019 | None published | Source reportedE3 |
| Noubar Afeyan | Independent | 2010 | None published | Source reportedE3 |
| Sandra Horning | Independent | 2020 | Nominating and Corporate GovernanceNominating and Corporate Governance; Product and Technology · ChairProduct and Technology, chair | Source reportedE3 |
| Stéphane Bancel | Not independent | 2011 | None published | Source reportedE3 |
| François Nader | Independence not published | Not published | Compensation and Talent, chairNominating and Corporate Governance, chair | Source reportedE5 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Elizabeth Tallett | Elizabeth Tallett, Abbas Hussain | Not described in the published record |
| Audit · Chair; Compensation and Talent | Not published | Elizabeth Tallett | human_capital |
| Audit; Product and Technology | Not published | Abbas Hussain | Not described in the published record |
| Compensation and Talent | François Nader | François Nader, Elizabeth Nabel, Elizabeth Tallett | human_capital |
| Compensation and Talent; Product and Technology | Not published | Elizabeth Nabel | human_capital |
| Nominating and Corporate Governance | François Nader | François Nader, David Rubenstein, Sandra Horning | Not described in the published record |
| Nominating and Corporate Governance; Product and Technology · Chair | Not published | Sandra Horning | Not described in the published record |
| Product and Technology | Sandra Horning | Sandra Horning, Abbas Hussain, Elizabeth Nabel | Not described in the published record |
Committee RecordAudit: Chair Elizabeth Tallett; Members Elizabeth Tallett (Chair); Abbas Hussain
Committee AppointmentElizabeth Tallett: chair, Audit
Committee AppointmentAbbas Hussain: member, Audit
Committee AppointmentFrançois Nader: chair, Compensation and Talent
Committee AppointmentElizabeth Nabel: member, Compensation and Talent
Committee AppointmentElizabeth Tallett: member, Compensation and Talent
Committee RecordNominating and Corporate Governance: Chair François Nader; Members François Nader (Chair); David Rubenstein; Sandra Horning
Committee AppointmentFrançois Nader: chair, Nominating and Corporate Governance
Committee AppointmentDavid Rubenstein: member, Nominating and Corporate Governance
Committee AppointmentSandra Horning: member, Nominating and Corporate Governance
Committee RecordProduct and Technology: Chair Sandra Horning; Members Sandra Horning (Chair); Abbas Hussain; Elizabeth Nabel
Committee AppointmentSandra Horning: chair, Product and Technology
Committee AppointmentAbbas Hussain: member, Product and Technology
Committee AppointmentElizabeth Nabel: member, Product and Technology
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingMRNA (NASDAQ)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NASDAQ: MRNA | current | Jul 21, 2021 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameModerna, Inc.
Entity StatusPublic listing published
Official Websitehttps://www.modernatx.com
Published FactUS
Published FactDE
Published FactHealthcare
Published Facthttps://www.modernatx.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Juan AndresChief Operating Officercompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:17
- Abbas HussainDirectorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:9
- David RubensteinDirectorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:10
- Elizabeth NabelDirectorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:11
- Elizabeth TallettDirectorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:12
- François Nader, M.D.Directorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:13
- Noubar AfeyanDirectorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:14
- Sandra HorningDirectorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:15
- Stéphane BancelDirectorcompany:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:leadership_role:16
- François NaderDirector (committee appointment)company:3ff53494-3800-4bc5-a2c8-0e3e54897d6c:committee_record:21
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 6 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 6 Claims.
- E2Moderna, Inc. Form 10-K (filed 2026-02-20). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec proxy. Published Mar 16, 2026. Retrieved Mar 21, 2026. Cited by 8 Claims.
- E4sec filing. Published Sep 30, 2026. Retrieved Sep 30, 2026. Cited by 1 Claim.
- E5board_seats. board seats. Cited by 15 Claims.
- E6Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Juan Andres executive of Moderna, effective 2026-10-05.
- Abbas Hussain seat on Moderna, effective 2024-01-01.
- David Rubenstein seat on Moderna, effective 2024-01-01.
- Audit; Product and Technology committee of Moderna, effective 2024-01-01.
- Abbas Hussain member of Audit; Product and Technology, effective 2024-01-01.
- David Rubenstein member of Nominating and Corporate Governance, effective 2024-01-01.
- Elizabeth Tallett seat on Moderna, effective 2020-01-01.
- Sandra Horning seat on Moderna, effective 2020-01-01.
- Audit · Chair; Compensation and Talent committee of Moderna, effective 2020-01-01.
- Elizabeth Tallett member of Audit · Chair; Compensation and Talent, effective 2020-01-01.
- Nominating and Corporate Governance; Product and Technology · Chair committee of Moderna, effective 2020-01-01.
- Sandra Horning member of Nominating and Corporate Governance; Product and Technology · Chair, effective 2020-01-01.
- François Nader, M.D. seat on Moderna, effective 2019-01-01.
- Elizabeth Nabel seat on Moderna, effective 2015-01-01.
- Compensation and Talent; Product and Technology committee of Moderna, effective 2015-01-01.
- Elizabeth Nabel member of Compensation and Talent; Product and Technology, effective 2015-01-01.
- Stéphane Bancel seat on Moderna, effective 2011-01-01.
- Noubar Afeyan seat on Moderna, effective 2010-01-01.